It’s already used for processing powders in many industries, but here’s why pastillation should come to pharma next.

Three regulatory pathways for drug–device combinations – and why early action is key.

Data is power when it comes to batch-quality prediction and obtaining the coveted perfect profile.

Experts from the Access to Medicine Foundation discuss how to reduce the risk of antimicrobial resistance (AMR) in antibiotic manufacturing.

The use of multimodal chromatography is increasing in biopharma purification processes. Here’s why.

Experts suggest that outsourcing CGT manufacturing capabilities to CDMOs brings additional benefits, although not without challenges

Experts from Emergent BioSolutions break down the qualities that make an ideal CDMO partner for plasma- based protein manufacturing

Navigating the cell therapy partnership selection process can be complex. Here, I share the questions you should be asking to help you get it right.

Is renting material handling equipment the best way to help manufacturers tackle waste?